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Background
Nr
Lymphatic drainage of renal cell carcinoma (RCC) is unpredictable
and the role of lymph node dissection (LND) remains controversial.
However, adjuvant studies with checkpoint inhibitors have sparked
new interest in accurate pathological lymph node staging in RCC.
Recently, sentinel lymph node (SN) studies revealed the pattern of
lymphatic drainage from renal tumours¹²³. Nevertheless, it is
unknown if the location of early pN1 lymph node metastases found
at LND match the SN drainage pattern .
Aim of the study
Materials & Methods
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To describe the location of single- or oligo-metastatic lymph nodes
and analyze if the pattern of this early lymphonodular tumour
drainage matches the drainage pattern observed in SN studies of
renal tumours¹²³.
Results
Early single- or oligo-metastatic LNs in renal cancer are mainly located
in the hilar, retro- and interaortocaval region on the right side and
paraaortal region on the left side. These locations match with the
drainage pattern reported in SN trials. MFS for occult lymph node
metastatic patients is not better compared to cN1 cases. However, the
outcome needs to be reproduced in a larger cohort.
After institutional review board approval, we collected data from 5
different centers from 1990-2018 of all patients with pT1-4 M0 RCC
with pathologically confirmed single- or oligo-metastases in
locoregional lymph nodes, presenting as either cN0 or a single cN1
node on imaging. Collected data included location of the lymph node
metastases, number, size of metastatic lymph nodes and survival. We
analyzed the data using descriptive statistics showing the location of
metastatic lymph nodes and Kaplan Meier survival models for
evaluating survival differences between cN0/pN1 and cN1/pN1 cases
using SPSS version 22 (IBM, Chicago, IL, USA).
We identified a total of 49 patients, with histologically confirmed pN1, of
whom 16 (32.7%) and 33 (67.3%) with cN0 and cN1 at diagnosis,
respectively. The majority (36 73.5%) represented clear cell RCC. The right
side was involved in 26 (53.1%) and the left side in 23 (46.9%) patients.
Primary tumours were pT2b in 26.5% and pT3a in 32.7%. The median
number of detected LN metastases at LND was 2.0 (IQR 1-3) with a median
number of LNs removed of 4.5 (IQR 2-8.7).
On the left side, LN metastases were predominantly located in the
paraaortal (34.7% (95% CI 17.19-57.18%)) and hilar (30.4% (95%CI 14.05-
53.0%)) area, matching the paraaortal and hilar drainage observed in SN
studies.
On the right side, metastases located in retrocaval (23.0% 95% CI 9.7-
44.0%)), hilar (23.0% 95% CI 9.7-44.0%)) and interaortocaval (11.5%
95%CI 3.0-31.2%)) LNs, following the drainage pattern reported in SN
studies on the right side.
There was no statistical significant distant metastasis free survival (MFS)
between cN0/pN1 or cN1/pN1 patients.
Kaplan Meier curve showing metastases-free survival of  cN0 and cN1 all pN1 lymph 
node oligometastatic RCC cases.  
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A. Bar chart showing pN1 metastatic LN locations on right and left side.
Log rank p=0.04
Right and left renal cancer sites of cN0 (white) and cN1 (yellow) metastatic lymph nodes. 
Yellow lymph nodes without filling are dorsally located, retrocaval lymph nodes. 
Time (months) 0 6 12 19 24 28 58
cN0 16 5 3 2 2 1 0
cN1 33 13 8 2 1 0 0
Risk table
